162 related articles for article (PubMed ID: 34919892)
1. The Impact of Persistent Smoking After Surgery on Long-term Outcomes After Stage I Non-small Cell Lung Cancer Resection.
Heiden BT; Eaton DB; Chang SH; Yan Y; Schoen MW; Chen LS; Smock N; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
Chest; 2022 Jun; 161(6):1687-1696. PubMed ID: 34919892
[TBL] [Abstract][Full Text] [Related]
2. Association Between Surgical Quality Metric Adherence and Overall Survival Among US Veterans With Early-Stage Non-Small Cell Lung Cancer.
Heiden BT; Eaton DB; Chang SH; Yan Y; Baumann AA; Schoen MW; Tohmasi S; Rossetti NE; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
JAMA Surg; 2023 Mar; 158(3):293-301. PubMed ID: 36652269
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
[TBL] [Abstract][Full Text] [Related]
4. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.
Park BJ; Melfi F; Mussi A; Maisonneuve P; Spaggiari L; Da Silva RK; Veronesi G
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):383-9. PubMed ID: 22104677
[TBL] [Abstract][Full Text] [Related]
5. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
6. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.
Kim HK; Cho JH; Choi YS; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Kim K; Kim J
Lung Cancer; 2016 Jun; 96():56-62. PubMed ID: 27133751
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.
Chang JY; Mehran RJ; Feng L; Verma V; Liao Z; Welsh JW; Lin SH; O'Reilly MS; Jeter MD; Balter PA; McRae SE; Berry D; Heymach JV; Roth JA;
Lancet Oncol; 2021 Oct; 22(10):1448-1457. PubMed ID: 34529930
[TBL] [Abstract][Full Text] [Related]
10. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer.
Yang CF; Adil SM; Anderson KL; Meyerhoff RR; Turley RS; Hartwig MG; Harpole DH; Tong BC; Onaitis MW; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1607-13. PubMed ID: 26719403
[TBL] [Abstract][Full Text] [Related]
11. Impact of Surgeon Volume on Outcomes of Older Stage I Lung Cancer Patients Treated via Video-assisted Thoracoscopic Surgery.
Smith CB; Wolf A; Mhango G; Wisnivesky JP
Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):223-230. PubMed ID: 28823334
[TBL] [Abstract][Full Text] [Related]
12. Institutional-Level Differences in Quality and Outcomes of Lung Cancer Resections in the United States.
Osarogiagbon RU; Sineshaw HM; Lin CC; Jemal A
Chest; 2021 Apr; 159(4):1630-1641. PubMed ID: 33197400
[TBL] [Abstract][Full Text] [Related]
13. The impact of emphysema on surgical outcomes of early-stage lung cancer: a retrospective study.
Sato S; Nakamura M; Shimizu Y; Goto T; Koike T; Ishikawa H; Tsuchida M
BMC Pulm Med; 2019 Apr; 19(1):73. PubMed ID: 30947705
[TBL] [Abstract][Full Text] [Related]
14. The Persistent Problem of Local/Regional Failure After Surgical Intervention for Early-Stage Lung Cancer.
Judy GD; Kaidar-Person O; Deal A; Wang Y; Migliardi A; Long J; Haithcock B; Marks LB
Ann Thorac Surg; 2018 Aug; 106(2):382-389. PubMed ID: 29723532
[TBL] [Abstract][Full Text] [Related]
15. Predictors and outcomes of limited resection for early-stage non-small cell lung cancer.
Billmeier SE; Ayanian JZ; Zaslavsky AM; Nerenz DR; Jaklitsch MT; Rogers SO
J Natl Cancer Inst; 2011 Nov; 103(21):1621-9. PubMed ID: 21960708
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy and Surgical Resection for N1 Positive Non-small Cell Lung Cancer: Better Than Expected Outcomes.
White A; Kucukak S; Lee DN; Mazzola E; Dolan D; Bueno R; Jaklitsch MT; Swanson SJ
Semin Thorac Cardiovasc Surg; 2021; 33(4):1105-1111. PubMed ID: 33600992
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
Heiden BT; Eaton DB; Engelhardt KE; Chang SH; Yan Y; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
JAMA Netw Open; 2021 May; 4(5):e2111613. PubMed ID: 34042991
[TBL] [Abstract][Full Text] [Related]
18. Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer?
Shah AA; Worni M; Kelsey CR; Onaitis MW; D'Amico TA; Berry MF
Ann Thorac Surg; 2013 May; 95(5):1700-7. PubMed ID: 23545195
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.
Yang CJ; Gu L; Shah SA; Yerokun BA; D'Amico TA; Hartwig MG; Berry MF
Lung Cancer; 2018 Jan; 115():75-83. PubMed ID: 29290266
[TBL] [Abstract][Full Text] [Related]
20. Surgery on unfavourable persistent N2/N3 non-small-cell lung cancer after trimodal therapy: do the results justify the risk?
Steger V; Walker T; Mustafi M; Lehrach K; Kyriss T; Veit S; Friedel G; Walles T
Interact Cardiovasc Thorac Surg; 2012 Dec; 15(6):948-53. PubMed ID: 22997251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
